Emami Limited Reports Strong Performance with ₹3,809 Crore Revenue and 26.9% EBITDA Margin
Emami Limited released a corporate presentation showcasing strong financial performance with ₹3,809.00 crore revenue and 26.90% EBITDA margin. The company maintains market leadership in cool oils (67.50% share) and antiseptic creams (60.10% share). Emami's global presence spans 145 countries, with international business contributing 17% of revenue. The company remains debt-free with 33.40% ROE and 32.60% ROCE. Future growth strategies include power brand focus, innovation, digital transformation with Zanducare launch, international expansion, and ESG initiatives.

*this image is generated using AI for illustrative purposes only.
Emami Limited , a leading personal care and healthcare company, has released a corporate presentation highlighting its robust performance and business overview. The company has demonstrated steady growth and maintained strong market positions across various product segments.
Financial Highlights
Emami reported a revenue of ₹3,809.00 crore, showcasing a 5-year Compound Annual Growth Rate (CAGR) of 7.50%. The company's EBITDA margin stood at an impressive 26.90%, reflecting its operational efficiency and strong brand portfolio.
Product Portfolio and Market Leadership
Emami's diverse product range spans multiple segments, each contributing significantly to the company's revenue:
Product Range | Revenue |
---|---|
Navratna Range | ₹850.00 crore |
Pain Management Range | ₹850.00+ crore |
BoroPlus Range | ₹600.00+ crore |
Kesh King Range | ₹300.00+ crore |
Male Grooming Range | ₹200.00+ crore |
The company maintains market leadership positions in key categories:
- Cool oils: 67.50% volume share
- Antiseptic creams: 60.10% volume share
Global Presence and Distribution
Emami has established a strong presence both domestically and internationally:
- Present in over 145 countries
- Reaches 5.4 million retail outlets in India
- International business contributes 17% of revenue
- Acquired brands account for 28% of revenue
Financial Strength and Shareholder Returns
The company's financial position remains robust:
- Debt-free status
- Return on Equity (ROE): 33.40%
- Return on Capital Employed (ROCE): 32.60%
- Adjusted Profit After Tax (PAT): ₹899.00 crore
Strategic Initiatives and Future Outlook
Emami has outlined several strategic initiatives to drive future growth:
Power Brand Strategy: The company is focusing on future-proofing its power brands through holistic consumer engagement, increased market penetration, and expansion into new geographies.
Innovation and Brand Repositioning: Emami is fueling growth through youth-driven innovation and brand repositioning to increase its Total Addressable Market (TAM).
Digital Transformation: The company has launched Zanducare, a digital healthcare ecosystem and e-commerce portal for Zandu Healthcare products, offering a curated portfolio of Ayurvedic products with personalized recommendations.
International Expansion: Emami is consolidating its presence in key global markets, with a focus on the top 15 countries that contribute approximately 85% of its global revenues.
ESG Initiatives: The company has made significant progress in its environmental, social, and governance (ESG) efforts, including reducing energy and water consumption, increasing renewable energy usage, and implementing strong governance practices.
Conclusion
Emami Limited's strong financial performance, diverse product portfolio, and strategic initiatives position it well for continued growth in the personal care and healthcare sectors. The company's focus on innovation, digital transformation, and sustainability aligns with evolving consumer preferences and market trends, setting the stage for future success.
Note: All financial figures and market share data are based on the company's corporate presentation.
Historical Stock Returns for Emami
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
+2.21% | +2.10% | +0.60% | +10.02% | -25.97% | +75.03% |